Reactions with Antisera and Pathological Effects of Staphylococcus aureus Gamma-Toxin in the Cornea

ABSTRACT Purpose: This study analyzed the toxicity of purified gamma-toxin from Staphylococcus aureus and the protectiveness of antisera to gamma-toxin in the rabbit cornea. Materials and methods: Gamma-toxin was purified from cultures of alpha-toxin deficient S. aureus strain Newman Δhla. Antisera to native gamma-toxin (Hlg) were produced in rabbits. These antisera and a commercial polyclonal antibody to recombinant HlgB (rHlgB) were analyzed for specificity and toxin neutralization. Heat-inactivated gamma-toxin, active gamma-toxin either alone or with antisera or with commercial antibody to rHlgB, was injected into the rabbit cornea to observe the pathological effects using slit lamp examination scoring (SLE) and histological analyses. Results: Eyes with intrastromal injection of gamma-toxin developed SLE scores that were significantly higher than eyes injected with heat-inactivated gamma-toxin (p ≤ 0.003). Slit lamp and histological examination of eyes revealed that gamma-toxin injected into the cornea mediated conjunctival injection and chemosis, iritis, fibrin accumulation in the anterior chamber, and polymorphonuclear neutrophil infiltration of the cornea and iris. Also, eyes injected with gamma-toxin plus antisera to native whole gamma-toxin or HlgB, but not with commercial antibody to rHlgB, yielded significantly lower SLE scores than eyes injected with gamma-toxin alone (p ≤ 0.003). Conclusions: This study illustrates that S. aureus gamma-toxin is capable of causing significant corneal pathology. Furthermore, the use of polyclonal antisera specific for native gamma-toxin was found to inhibit the damaging effects of the toxin in the rabbit cornea.

[1]  R. O'Callaghan,et al.  Effectiveness of Alpha-toxin Fab Monoclonal Antibody Therapy in Limiting the Pathology of Staphylococcus aureus Keratitis , 2015, Ocular immunology and inflammation.

[2]  K. Rigby,et al.  Staphylococcal alpha‐phenol soluble modulins contribute to neutrophil lysis after phagocytosis , 2013, Cellular microbiology.

[3]  G. Pier,et al.  Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology. , 2013, Investigative ophthalmology & visual science.

[4]  H. Flynn,et al.  Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. , 2013, American journal of ophthalmology.

[5]  M. Horsburgh,et al.  Recurrent bacterial keratitis. , 2013, Investigative ophthalmology & visual science.

[6]  D. Himmelstein,et al.  Infective Endocarditis in the U.S., 1998–2009: A Nationwide Study , 2013, PloS one.

[7]  P. Schlievert,et al.  Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. , 2012, Vaccine.

[8]  I. Tanaka,et al.  Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components , 2011, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Lebbink,et al.  Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins , 2011, Proceedings of the National Academy of Sciences.

[10]  M. Willcox.  Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins , 2011, Clinical & experimental optometry.

[11]  Scott D. Smith,et al.  Epidemiology of ulcerative keratitis in Northern California. , 2010, Archives of ophthalmology.

[12]  John A. Wright,et al.  Interaction of staphylococci with bone , 2010, International journal of medical microbiology : IJMM.

[13]  Kelly K Nichols,et al.  Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. , 2009, The ocular surface.

[14]  T. Proft,et al.  The bacterial superantigen and superantigen‐like proteins , 2008, Immunological reviews.

[15]  F. G. van der Goot,et al.  Pore formation: an ancient yet complex form of attack. , 2008, Biochimica et biophysica acta.

[16]  M. Gilmore,et al.  Staphylococcus aureus—Probing for Host Weakness? , 2008, Journal of bacteriology.

[17]  L. Mourey,et al.  Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions. , 2006, The Biochemical journal.

[18]  W. Feuer,et al.  Update on bacterial conjunctivitis in South Florida. , 2006, Ophthalmology.

[19]  G. Sloop,et al.  Effects of toxin production in a murine model of Staphylococcus aureus keratitis. , 2005, Investigative ophthalmology & visual science.

[20]  A. Bayer,et al.  A rot Mutation Restores Parental Virulence to an agr-Null Staphylococcus aureus Strain in a Rabbit Model of Endocarditis , 2005, Infection and Immunity.

[21]  H. Flynn,et al.  Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. , 2004, American journal of ophthalmology.

[22]  S. Eykyn,et al.  Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. , 2003, Survey of ophthalmology.

[23]  R. O'Callaghan,et al.  Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. , 2002, DNA and cell biology.

[24]  T. Foster,et al.  Corneal pathogenesis of Staphylococcus aureus strain Newman. , 2002, Investigative ophthalmology & visual science.

[25]  H. Bayley,et al.  Subunit composition of a bicomponent toxin: Staphylococcal leukocidin forms an octameric transmembrane pore , 2002, Protein science : a publication of the Protein Society.

[26]  Michael S. Gilmore,et al.  Bacterial Endophthalmitis: Epidemiology, Therapeutics, and Bacterium-Host Interactions , 2002, Clinical Microbiology Reviews.

[27]  R N Jones,et al.  Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  E. Hume,et al.  Immunization with Alpha-Toxin Toxoid Protects the Cornea against Tissue Damage during Experimental Staphylococcus aureus Keratitis , 2000, Infection and Immunity.

[29]  G. Alexandrakis,et al.  Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.

[30]  M. Gilmore,et al.  Pathogenesis of Gram-Positive Bacterial Endophthalmitis , 1999, Infection and Immunity.

[31]  T. Foster,et al.  Alpha-Toxin and Gamma-Toxin Jointly PromoteStaphylococcus aureus Virulence in Murine Septic Arthritis , 1999, Infection and Immunity.

[32]  T. Foster,et al.  Surface protein adhesins of Staphylococcus aureus. , 1998, Trends in microbiology.

[33]  A. Gravet,et al.  Characterization of a novel structural member, LukE‐LukD, of the bi‐component staphylococcal leucotoxins family , 1998, FEBS letters.

[34]  G. Archer.  Staphylococcus aureus: a well-armed pathogen. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  T. Foster,et al.  Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. , 1998, Microbial pathogenesis.

[36]  G. Sloop,et al.  Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. , 1997, Current eye research.

[37]  J. Sahel,et al.  Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. , 1997, Journal of medical microbiology.

[38]  T. Foster,et al.  Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection , 1997, Infection and immunity.

[39]  M. Gilmore,et al.  Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis , 1997, Infection and immunity.

[40]  J. A. Hobden,et al.  Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. , 1996, Investigative ophthalmology & visual science.

[41]  J. Iandolo,et al.  Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. , 1995, Investigative ophthalmology & visual science.

[42]  A. Tarkowski,et al.  The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model , 1993, Infection and immunity.

[43]  J. McCulley,et al.  Comparative bacteriology of chronic blepharitis. , 1984, The British journal of ophthalmology.

[44]  U. Nübel,et al.  Staphylococcus aureus toxins--their functions and genetics. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[45]  H. Flynn,et al.  Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. , 2004, American journal of ophthalmology.

[46]  R. O'Callaghan.  Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998. , 1999, Cornea.

[47]  A. Karabulut,et al.  Conjunctival impression cytology and tear-film changes in patients with psoriasis. , 1999, Cornea.

[48]  M. Terpenning.  Infective endocarditis. , 1992, Clinics in geriatric medicine.

[49]  G. Prévost,et al.  Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. , 1991, Research in microbiology.

[50]  M. Plommet.  Preparation and purification of gamma-hemolysin of staphylococci. , 1988, Methods in enzymology.